Kyle Schlunegger
Director Project Management / Alliance Manager at Halozyme Therapeutics, Inc. | San Diego County, California, United States
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
Kyle Schlunegger serves as the Associate Director of Project Management at Halozyme Therapeutics, Inc., where he plays a pivotal role in advancing the company’s innovative Enhanze® drug delivery technology. With over 20 years of experience in the biotechnology and pharmaceutical industries, Kyle has honed his expertise in managing complex technology projects, guiding them from conception through to successful launch. His extensive background encompasses a wide range of functions, including Project Management, Manufacturing, Quality Assurance, Clinical Development, Supply Chain, and Research, allowing him to lead multi-disciplinary teams effectively.
At Halozyme, Kyle is instrumental in fostering strategic alliances that leverage the Enhanze® platform, which enhances the delivery of biologics and improves patient outcomes. His adeptness in navigating the regulatory landscape, particularly with the U.S. Food and Drug Administration (FDA), ensures that projects align with compliance standards while meeting ambitious timelines. Kyle’s strong program management skills, coupled with his ability to communicate complex concepts clearly, enable him to present project updates and strategic insights to senior management and stakeholders confidently.
In addition to his project management acumen, Kyle is deeply involved in validation processes and assay development, ensuring that all aspects of the drug delivery technology meet rigorous scientific and regulatory standards. His leadership style fosters collaboration and innovation, empowering team members to contribute their expertise and drive project success. As the biopharmaceutical landscape continues to evolve, Kyle’s commitment to excellence and his strategic vision position him as a key player in the advancement of cutting-edge therapeutic solutions at Halozyme.
Director Project Management / Alliance Manager at Halozyme Therapeutics, Inc. in April 2019 to Present
Director Project Management at Halozyme Therapeutics, Inc. in April 2019 to Present
Senior Project Manager at Pfenex Inc in October 2016 to April 2019
Senior Project Manager at Peregrine Pharmaceuticals in July 2008 to October 2016
Project Leader at Peregrine Pharmaceuticals in January 2006 to July 2008
Manager of contract production at Peregrine Pharmaceuticals in October 2001 to January 2006
Methods Development Manager at Alpha Therapeutic Corporation in September 1996 to October 2001
Analytical Chemist/Management at Health Science Associates in January 1993 to January 1997
See more
See less
California State University, Long Beach, BS, November 1993 to November 1995
California State University, Long Beach, Minor, November 1992 to November 1993
California State University, Long Beach, BS, November 1988 to November 1992
See more
See less
Strategy
Team Leadership
Investigational New Drug Application (IND)
Critical Thinking
Clinical Research
Clinical Trials
Clinical Development
Contract Management
Project Planning
Teamwork
U.S. Food and Drug Administration (FDA)
Biotechnology
Validation
Pharmaceutical Industry
Biopharmaceuticals
Assay Development
Program Management
Project Management
Presentation Skills
Public Speaking
See more
See less
Discover more about Halozyme Therapeutics, Inc.What is Kyle Schlunegger email address?
Email Kyle Schlunegger at [email protected] and [email protected]. This email is the most updated Kyle Schlunegger's email found in 2026.
How to contact Kyle Schlunegger?
To contact Kyle Schlunegger send an email to [email protected] or [email protected]. (updated on September 03, 2024)
What company does Kyle Schlunegger work for?
Kyle Schlunegger works for Halozyme Therapeutics, Inc.
What is Kyle Schlunegger's role at Halozyme Therapeutics, Inc.?
Kyle Schlunegger is Director Project Management / Alliance Manager
What is Kyle Schlunegger's Phone Number?
Kyle Schlunegger's phone (213) ***-*360
What industry does Kyle Schlunegger work in?
Kyle Schlunegger works in the Biotechnology industry.
Kyle Schlunegger Email Addresses
Kyle Schlunegger Phone Numbers
Get a free list of similar prospects, filtered by title, company, or industry.
Build your Prospect ListPeople like Kyle Schlunegger
Dynamics 365 DevOps Engineer at Epoch Concepts
Information Technology Web Developer at Music Alliance Academy
Data Science Senior Manager at Albertsons Companies
Executive Assistant to VP Head of Quality at Halozyme, Inc.
Vice President, Human Resources at Halozyme Therapeutics, Inc.
Sr. Mgr. Quality Audits at Halozyme Therapeutics, Inc.
Renal Specialist at AstraZeneca
Texas Real Estate Agent at Self
Regional Business Director at Insight Medical Genetics
IT Program Management Manager at Briggs & Stratton
Vice President at MUFG
Managing Director at Golub Capital
Sr Manager - Systems Engineering at Edwards Lifesciences
Sr. Network Infrastructure Architect at IBM
MTS at eBay
Managing Director North America at DRS Group
Director at Custom Iron and Ston LLC
Territory Account Manager at Koorsen Fire and Security
Steering Committee Member at OEDIT Opportunity Zones Steering Committee
Behavioral Health Tech at West Yavapai Guidance Clinic
Operations Director at The Adanta Group
Senior Software Engineer at JPMorgan Chase & Co.
Senior Manager, Business Readiness, Network Team at Crown Castle
Support Revenue Account Manager at System Innovators
Channel Development Manager at Kyruus
Safety Director at Jimco Electrical Contracting, Inc
Show more
Show less